OUR TEAM
Our team combines experienced healthcare informatics professionals with expert clinicians from leading AMCs
An Illumina Accelerator company, we have partnered with leading Academic Medical Centers to develop the world’s leading AI-powered clinico-genomic platform for rare disease drug research and development
Meet our leadership team
CEO / Founder
Simon Kennedy
VP, Data and Analytics
Vlad Valtchinov, PhD
Director, Health Strategy
Bennet Lane, MD
Senior Advisor / Co-Founder
J. Marc Overhage MD, PhD
Meet our scientific advisory team
Rare Disease Patient Advisor
Jonathan White, MD
Senior Advisor
Robert Epstein, MD
BioPharma Discovery Advisor
Tanya Moreno, PhD
Scientific Advisory Board for Pulmonary Rare Disease
Massachusetts General Brigham
Aaron Waxman, MD, PhD
Weill Cornell
Evelyn Horn, MD
The University of Arizona
Franz Rischard, DO
University of Pittsburgh Medical Center
Michael Risbano, MD
Mount Sinai
Raymond Benza, MD
Stanford University School of Medicine